EE106 Cost-Effectiveness Analysis of Bimekizumab in Patients With Moderate-to-Severe Plaque Psoriasis in Greece
Abstract
Authors
M Koulentaki C Tzanetakos A Stratigos E Sotiriou I Ladha P Christou J Relakis G Kourlaba
M Koulentaki C Tzanetakos A Stratigos E Sotiriou I Ladha P Christou J Relakis G Kourlaba
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now